IMI 6: The Immune Response Against Extracellular Pathogens Flashcards

1
Q

Observe the learning outcomes of this session

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What do the first barriers to infection consist of?

Give some examples

A
  • physical barriers
  • mechanical barriers
  • chemical barriers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where do the mucosal membranes cover?

A
  • the gastrointestinal tract
  • upper and lower respiratory tract
  • urogenital tract
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the commensal microbiome?

A
  • the collective of microorganisms present on our mucous membranes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe some key features of commensal microorganisms

A
  • The microbiome represents a competitive environment for pathogens.
  • Resident commensal bacteria, for example, can secrete antibiotics and antimicrobial peptides called bacteriocins that act against competitor microorganisms, creating an effective first line of defence against invading pathogens.
  • Commensal bacteria provide some advantages for the host.
  • For example, they produce molecules such as vitamin K and B12, which are essential for the proper functioning of our bodies.
  • They are also fundamental in breaking down plant fibres and inactivating toxic substances found in food.
  • Some of these harmless bacteria can become pathogenic if they cross the mucosal barrier or relocate to a different anatomical district.
  • Staphylococcus epidermidis lives on our skin and is harmless but after damage, for example a cut, it can penetrate the barriers and trigger inflammation;
  • Pseudomonas aeruginosa is commonly found in water and most of us can fight it effectively.
  • However, it can infect the airways, urinary tract and wounds of vulnerable individuals and cause real harm (e.g. by causing pneumonia and in some cases sepsis).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Observe this diagram of the immune system

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How much of the entire immune system do mucosal-associated lymphoid tissues (MALT) represent?

A
  • 70%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe how gut tissue and the gut-associated lymphoid tissue (GALT) is organised

A
  • The gut mucosa is composed of a layer of epithelial cells that are in contact with the intestinal lumen and a layer of connective tissue called lamina propria populated by cells of the immune system.
  • The epithelial cells are structurally and functionally diverse.
  • For example, the enterocytes are covered in microvilli and are specialised in the absorption of digested nutrients, whilst others have an important role in maintaining the immune homeostasis of the gut
  • Figure legend: Cellular anatomy of gut mucosa tissue of the small intestine. A single layer of epithelial cells with diverse functions, including enterocytes covered with microvilli, Paneth cells secreting antimicrobial peptides, Goblet cells secreting mucus and anti-microbial peptides and entero-endocrine cells which produce important hormones involved in regulating the digestion. Disseminated within the epithelium are also the intraepithelial lymphocytes (IEL) a subset of T cells that don’t need priming and are able to directly respond to pathogens. Dendritic cells, Macrophages, B cells and T cells reside just below the epithelium in the mucosa. The lumen is populated by commensal bacteria which are kept under control by IgA produced by B cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the immune anatomy of the lamina propria

A
  • The lamina propria includes both resident immune cells and immune cells migrating from other lymphoid organs. Importantly the resident immune cells are organised into distinctive gut structures:
  • The Payer patches: have anatomical features that are similar to lymph nodes and they are present in the small intestine.
  • Isolated lymphoid follicles (ILFs): are located beneath the epithelial surface of both the small and large intestine and are formed by isolated B cells, mostly producing IgA.
  • The location of a variety of immune cells just below the epithelium is fundamental as it offers closer contact with the microorganisms present in the lumen
  • Figure legend: Organization of resident immune cells within the lamina propria. Secondary lymphoid tissue associated with the small intestine including Peyer’s patches organised with a structure similar to that of the lymph node and isolated lymphoid follicle.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is immune tolerance?

A
  • the absence of an immune response against a particular foreign body
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the steps of the tolerogenic response?

A
  1. Antigen sampling
  2. Release of tolerogenic molecules and Treg recruitment
  3. IgA secretion from plasma cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe step 1 ‘antigen sampling’ of the tolerogenic response

A
  • How can DCs sample antigens or sense the PAMPs of commensal organisms if they are in the gut lumen, separated from the immune cells by the epithelial layer?
  • The figure above illustrates some of the mechanisms involved in antigen sampling in the gut lumen.
  • As explained earlier the epithelial layer is formed by a heterogeneous population of cells.
  • Some of these cells have evolved the ability to secrete mucus and antimicrobial peptides but can also sample for antigens.
    1. Microfold or M cells are often associated with the Peyer’s patches and isolated lymphoid follicles.
  • Both M cells and Goblet cells move soluble antigens via transcytosis from the apical side to the basal side and release them in the lamina propria where dendritic cells are conveniently located.
    2. IgA-bound antigens (from IMI3 you should remember that this antibody subtype is secreted abundantly in the mucosal surfaces) are captured by an FcR𝝰 receptor present on the surface of epithelial cells and released to dendritic cells residing in the lamina propria via receptor-mediated transcytosis.
    3. Dendritic cells can directly sample for antigens in the intestinal lumen by extending cell processes called dendrites between epithelial cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe step 2 ‘release of tolerogenic molecules and Treg recruitment of the tolerogenic response

A
  • Epithelial cell interaction with commensal organisms via PRR or via IgA bound antigens also promotes the release of tolerogenic molecules, for example, TGF-beta, that program dendritic cells to release IL-10.
  • IL-10 is a potent anti-inflammatory cytokine that is produced when the mucosa is healthy, un-breached and populated by commensal organisms rather than pathogens.
  • When DCs migrate to the regional lymph node or the Peyer’s patches to present antigens to CD4+ helper T cells, they release IL-10.
  • This promotes the differentiation of helper T cells into regulatory T cells (Treg).
  • Tregs maintain the immune homeostasis producing more IL-10 and suppressing the immune response.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe Step 3 ‘IgA secretion from plasma cells’ in the tolerogenic response

A
  • The tolerogenic environment, particularly the presence of TGF-beta and IL-10, promotes also plasma cells present in the Peyer’s patches and in the ILFs (isolated lymphoid follicles), to switch class from IgM to IgA (if you need to refresh your memory on the mechanism of class switch recombination have a look at IMI3).
  • This can happen in a T cell-dependent or independent manner. In fact, some of the cytokines released by epithelial cells and dendritic cells can directly promote the production of IgA from B cells.
  • IgA dimers are transcytosed from the lamina propria to the intestinal lumen via polymeric Ig receptors on epithelial cells.
  • Once in the lumen IgAs bind antigens on the surface of commensal organisms.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What do IgA, antimicrobial peptides and mucus produced by Goblet cells do?

A
  • they keep commensal microorganisms at a safe distance
  • making the symbiotic relationship with the microbiome possible
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is an important difference between commensal organisms and pathogens?

A
  • pathogens release molecules aimed at damaging the barrier and penetrating it.
  • These include toxins, and lytic enzymes able to degrade the extracellular matrix and damage the epithelial layer allowing bacteria to penetrate, but also hair-like structures such as fimbriae and pili that make bacteria adhere to epithelial cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the first step pathogens make in the gut?

A
  • adhesion is sometimes the first step before the damage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the steps of the gut immune response to pathogens

A
  1. Inductive phase
  2. Effector phase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe Step 1 ‘Inductive phase’ of the gut immune response to pathogens

A
  • In the presence of a pathogen, PRRs on both epithelial cells and antigen-presenting cells will sense the presence of PAMPs that differ from those of commensal bacteria;
  • one of the consequences is the activation of the inflammasome and the secretion of inflammatory cytokines (IMI4).
  • An example of a PAMP is pilin: a protein present in bacterial fimbriae.
  • The shaping of the immune response mounted by antigen-presenting cells is called the inductive phase: after capturing the pathogen’s antigen DCs travel to the Peyer’s patches to alert naïve T helper cells of the danger.
  • Here they not only present the antigen but also release inflammatory cytokines that polarise helper T cells into the most appropriate subtype to fight the infection.
  • Examples include Th1, Th2, Th9 and Th17 depending on the type of pathogen invading the barrier.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe Step 2 ‘Effector phase’ of the gut immune response to pathogens

A
  • The most appropriate subtype of T helper cells will orchestrate the immune response by recruiting and activating other cells of the immune system to fight the infection.
  • This phase is called the effector phase.
  • One important event in the effector phase is the class switch of immunoglobulins in B cells to produce IgG (IMI3).
  • This class of antibodies is in fact found in all body fluid and provide full protection in case of a systemic infection.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Why do some epithelial cells express TLRs at the basolateral rather than the apical surface of the cell?

A
  • In this way, they are able to sense bacteria that have crossed the epithelium.
  • Thus they can tell the difference between invading bacteria and those that are localised in the gut lumen.
  • This is important to check for commensal organisms that do not pose any harm when they are confined in the gut lumen but can be potentially dangerous once they have crossed the barrier.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Watch this video which summarises the key points of mucosal immune responses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the role of microfold cells (the so-called M-cells)?

A
  • transcytosis of antigens
  • They transport soluble substances, stimulate the production of IgA (although they do not produce the antibodies themselves!), uptake antigen via endocytosis and move them via transcytosis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

How do we define an extracellular pathogen?

A
  • An extracellular pathogen invades the human body by crossing its protective barriers and spends some of its life-cycle (if not all) outside the cells of its host.
  • We are naturally prone to consider extracellular pathogens to be organisms like bacteria and in fact, most of this module will focus on these organisms. But let’s think again of the wide array of pathogens that can infect our body and their life cycle.
  • viruses are obligate intracellular pathogens, but before infecting the cell (step 1) and when they break out to infect new cells or new individuals (step 6) they are exposed to the extracellular environment and as such, they are potentially vulnerable to all the immune defences aimed at extracellular pathogens.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Describe some bacterial species that can live inside the cell

A
  • some bacterial species have evolved to live hidden inside the cell.
  • This is the case of Mycobacterium leprae which causes leprosy (see figure on the left).
  • Yersinia pestis, the infectious agent that causes the bubonic plague (or black death), the pandemic with the largest death toll ever recorded (75-200 million people) can live both inside and outside the cell, a strategy to elude the immune system!
27
Q

What are the main mediators of innate immunity?

A
  • barrier functions
  • the complement system
  • pattern recognition receptors
  • phagocytes
  • granulocytes
  • innate lymphoid cells
  • anti-microbial peptides
28
Q

What are the three key roles of the complement system?

A
  • opsonisation (tagging)
  • lysis of pathogens
  • attracting immune cells
29
Q

What is opsonisation?

A
  • marking a surface as foreign by adding specialised proteins called opsonins
  • making it more visible to the immune system
30
Q

What are the three main initiators of complement activation?

What pathways do they initiate

A
  • antibody initiates the classical pathway
  • bacterial cell wall components or PAMPs initiate the lectin pathway
  • spontaneous hydrolysis of complement initiates the alternative pathway
31
Q

Which pathway does the primary response arise from?

A
  • from the MBP/lectin complement pathway
  • which detects the sugar on molecules such as lipopolysaccharide (LPS) and peptidoglycan (PG) on the bacterial cell surface.
  • Despite generally being part of an adaptive response, antibodies that are involved in the activation of the classical complement pathway are also an important first line of defence against invading pathogens
32
Q

What are the functions of complement proteins?

A
  • Complement proteins can be covalently attached to any extracellular pathogen.
  • The first attachment creates a positive feedback loop cleaving and attaching more and more complement molecules to that surface.
  • This results in the pathogen opsonzation (B), allowing clearance by professional phagocytic cells (neutrophils and macrophages) through their complement receptors.
  • The release of cleavage byproducts of complement acts as a potent chemoattractant (C), potentiating the activation and migration of phagocytic cells and other cells of the immune system to the site of infection.
  • Finally, the membrane attack complex (MAC) inserted into the pathogen’s membrane causes direct damage and lysis (A) of the target extracellular pathogen
33
Q

Describe some mechanisms that pathogens have evolved to reduce complement recognition and effectiveness

A
  • protease-mediated destruction:
  • Haemophilus influenzae, a Gram-negative bacterium causing different kinds of infection mostly in infants, secretes an enzyme (protease) able to accelerate the breakdown of complement proteins.
  • binding and inactivation of the complement components:
  • Staphylococcus aureus, is a Gram-positive bacterium commonly found in the skin that can cause serious infection if it breaks the skin barrier.
  • It secretes bacterial proteins that function as a decoy for some of the complement components.
  • For example, they can bind and inhibit the C3 convertase
  • microbial mimicry of complement regulatory components:
  • To avoid the complement destroying its own cells, our body produces some inhibitory molecules that act as a security lock so that the complement is active only when necessary.
  • Staphylococcus pyogenes is a Gram-positive bacterium associated with infections in the skin and oropharynx.
  • It expresses complement inhibitory proteins, similar to that produced by our body, which deactivate the complement once it is deposited on its surface.
34
Q

Describe the membrane attack complex (MAC) and how it differs between gram-positive and gram-negative bacteria

A
  • The membrane attack complex (MAC) can directly damage pathogens by perforating their outer layer.
  • However, it is worth mentioning that the susceptibility of gram-positive and gram-negative bacteria to the MAC is very different because of the fundamental structural differences between these two groups of bacteria.
  • The MAC is able to penetrate the outer (and sometimes the inner) membrane of gram-negative bacteria and enveloped viruses (IMI7) causing effective damage, but cannot get through the thick peptidoglycan wall of most gram-positive bacteria to reach the membrane.
35
Q

What is PRRs role in the innate immune response to extracellular pathogens?

A
  • although PRRs do not cause direct damage to extracellular pathogens they are extremely important in sensing the presence of pathogens.
  • PRRs activate signalling pathways that result in the production of cytokines, important messengers for the activation of the cellular arm of the immune system in response to extracellular pathogens.
36
Q

Which PRRs would be best suited to sensing bacteria outside the cell?

A
  • TLR1, 2 and 4 detect bacterial cell walls, while TLR5 can detect bacterial flagellin.
  • Some CLRs can also sense some bacteria (although they are more critical for sensing fungi).
  • MBP is also a PRR that initiates the complement cascade.
  • However, NOD-like receptors sense bacterial peptidoglycans inside the cell.
37
Q

Describe some mechanisms that pathogens have evolved to avoid sensing or the signalling of PRRs

A
  • interfering with sensing:
  • LPS is an important component of the outer layer of gram-negative bacteria
  • some bacteria have the ability to modify the fatty acid chain to avoid being sensed by TLR4
  • interfering with signalling:
  • some bacteria produce enzymes that interfere with the signalling pathway activated upon PRR/PAMP interaction, impairing the production of cytokines.
  • One example is the anthrax lethal toxin produced by Bacillus anthracis which is able to cleave key components of MAPK signalling.
38
Q

Describe the innate immune response to extracellular pathogens: phagocytosis

A
  • Professional phagocytes including neutrophils and macrophages scavenge and destroy small extracellular organisms.
  • They are covered with phagocytic receptors that allow them to recognise either particular molecules (PAMPs or DAMPs) on pathogen surfaces [scavenger receptors] or immune molecules like complement and antibodies attached to them [opsonin receptors] which act as tags for their removal.
  • Review the IMI2 eModule if you need to revise these concepts.
39
Q

Which mechanisms do phagocytic cells use to kill microbial cells?

A
  • The phagolysosome:
    1. Generate reactive oxygen species (ROS)
    2. Reduces pH to maintain the activity of the lysosmal enzymes (active at acidic pH)
    3. Digest bacteria with antimicrobial enzymes (e.g. lysozyme, proteolytic and hydrolytic enzymes, defensins)
40
Q

What are some strategies bacteria have evolved to escape phagocytosis?

A
  • inhibition of the phagosome acidification:
  • One important step of phagocytosis is the lowering of the pH which leads to the activation of the lysosomal enzymes once the lysosome has fused with the phagosome.
  • Mycobacterium tuberculosis inhibits acidification by secreting an enzyme that stops proton pumps from working.
  • inhibition of the phagosome fusion with the lysosome:
  • The fusion of the lysosome with the phagosome is controlled by a family of proteins called Rab GTPases.
  • Some of Mycobacterium tuberculosis cell wall components and secreted enzymes interfere with GTPase activity, resulting in the inability of the lysosome to fuse with the phagosome.
  • escaping the phagosome:
  • As you will see in more detail in IMI7, Listeria monocytogenes, is a Gram-positive bacterium that has evolved a mechanism to destroy the phagosome membrane and escape into the cytosol of the host cell.
41
Q

Describe the innate immune response: NETosis

A
  • as well as using phagocytosis, neutrophils can also entrap extracellular pathogens by forming neutrophil extracellular traps (NETs) made of neutrophil DNA, histones proteins and granule enzymes.
  • An example was given in the mucosal immunity video earlier in this eModule.
  • The formation of NETs occurs within 1-2 hours of neutrophils’ activation.
  • As the name suggests, NETs immobilises extracellular pathogens thereby reducing the spread of infection

https://youtu.be/TIFmtnSdolM

42
Q

What doe the failure of the removal of NETs lead to?

A
  • It may lead to the formation of auto-antibodies directed against NET components.
  • This, in turn, can result in the development of autoimmune diseases
43
Q

Describe the mechanisms of NETosis evasion

What pathogens have evolved these mechanisms?

A

Some respiratory pathogens such as group A Streptococcus, Bordetella pertussis, and Haemophilus influenza have evolved mechanisms to resist NETosis.

  • the inhibition of NETs release:
  • Neutrophils need to receive the appropriate signal for activation and release of NETs. Some bacteria induce the production of IL-10 from immune cells.
  • This is a potent anti-inflammatory cytokine that inhibits NETosis.
  • NET degradation:
  • Some bacteria release DNAse and degrade DNA which is the major component of NETs, rendering them unable to trap the pathogen.
  • Resistance to NETosis:
  • Some bacteria develop resistance to NETosis by building a thick capsule that resists the attack of noxious substances present in the granules associated with the NETs.
44
Q

Describe the diversity of MHC Class II genes

A
  • MHC class II genes are enormously diverse at the population level.
  • Each MHC class II molecule comprises 2 polypeptide chains, and there are three pairs of genes for conventional MHC class II molecules (for which our genome is diploid).
  • Thus each of our antigen-presenting cells can express 12 different MHC class II molecules (which have preferences for different groups of peptide antigens) as well as non-classical MHC molecules, such as those recognised by unconventional T cells (see IMI2 & IMI3).
  • Each MHC molecule is ‘promiscuous’ - able to bind many different peptides.
  • Thus combining this promiscuity with the variety of MHC molecules allows the immune system to present a wide range of peptides.
45
Q

What is an MHC Class II molecule’s function?

A
  • Phagocytosis of extracellular pathogens by antigen-presenting cells (APCs) including dendritic cells, macrophages and B cells is fundamental for the degradation and processing of antigens which are used for recruiting and educating the adaptive arm of the immune system.
  • the digested material from phagocytosis is loaded into MHC class II molecule and presented to CD4 positive T cells, which play a fundamental role in orchestrating the proper type of adaptive response.
46
Q

Describe the difference between MHC class I and class II

A
  • The key difference between MHC class I and MHC class II (the most relevant to this session) is their source of antigens.
  • MHC class II is loaded with extracellular antigen sampled and processed by APCs.
  • In contrast, MHC class I is loaded with endogenous antigens: those that have been produced and/or degraded inside the cell cytosol. This (and a specific exception to this rule) have been discussed in IMI5 and will be discussed further in the next module (IMI7).
47
Q

What are some mechanisms extracellular pathogens have evolved to evade antigen presentation via MHC class II

A
  • escaping phagocytosis:
  • We have already seen how bacteria escape phagocytosis, and by avoiding destruction, they avoid having antigens presented on MHC class II molecules.
  • reduce cell surface expression/degradation:
  • Salmonella typhimurium, a Gram-negative bacterium causing gastroenteritis in humans upon ingestion of contaminated food, reduces the surface expression of MHC class II by inducing its polyubiquitination and hence degradation.
48
Q

Thinking about how dendritic cells present antigens sampled whilst patrolling the body to naive T cells in the secondary lymphoid organs, can you think of any other mechanisms pathogens can use to evade antigen presentation?

A
  • after sampling the antigen, processing it and loading it onto MHC class II, dendritic cells migrate to the secondary lymphoid organs to present the antigen to T cells
  • some bacteria such as Yersinia pestis produce toxins that paralyse dendritic cells, effectively inhibiting the initiation of the adaptive arm of the immune system
49
Q

What does antigen presentation to T helper cells result in?

A
  • it results in the polarisation of CD4+ T helper cells into the most appropriate subtype for responding against extracellular pathogens
  • T helper cells will provide the signal for B cells to differentiate in plasma cells and produce antibodies, the most significant weapons the adaptive immunity deploys against extracellular pathogens
50
Q

What happens when pathogens interfere with aspects of the innate immune systems to prevent antigen presentation?

A
  • Where pathogens interfere with aspects of the innate immune systems to prevent antigen presentation (blocking any of sensing, opsonisation or phagocytosis, that we have previously mentioned) it will negatively affect the recruitment of T helper cells and adaptive immunity.
  • However, one mechanism which relates more specifically to the T cell response is the production by pathogens of a “superantigen” as we will explain next.
51
Q

What pathogens secrete superantigens?

Give examples

A
  • Many Gram-positive bacteria secrete soluble proteins called exogenous superantigens that induce overactivity of the immune response.
  • They include staphylococcal enterotoxins, toxic shock syndrome (TSS) toxin, and exfoliative dermatitis toxin.
  • For example, Staphylococcus aureus and Streptococcus pyogenes produce more than 20 superantigens, which can cause massive fatal food poisoning and toxic shock syndrome (rash, vomiting, multi-organ failure)
52
Q

What are superantigens?

A
  • A Superantigen is a protein that is able to bind the outside surfaces (ie not the part that binds antigen) of both MHC class II and TCR complexes, forming a cross-linking bridge between the two.
  • This tricks the T cell into thinking its TCR has bound an antigen, inducing activation regardless of the specificity of the TCR for a suitable antigen.
53
Q

What is produced after the widespread activation of T-cells by a superantigen?

A
  • This widespread activation that follows the cross-linking by a superantigen results in the overproduction of pro-inflammatory cytokines, by T helper (Th) cells.
  • This can lead to systemic toxicity (toxicity throughout the blood).
  • Thus, the food poisoning induced by the toxic shock syndrome (TSS) is a consequence of cytokine overproduction by T cells and APCs induced by superantigen-driven activation.
54
Q

What is the main advantage of superantigen-driven activation?

A
  • the main advantage of this strategy for the bacterium is that the host organism has less chance of developing an effective T cell memory response:
  • even if the immune system does make some memory T cells, they are likely to be mixed in with a much larger number of non-specific T cells that will swamp out the effective response.
  • Worse, the superantigen can crosslink and overstimulate existing memory T cells, causing them to become ‘exhausted’ and thus ineffective, or even tolerant for their target, or it could drive the activation of self-reactive T cells, leading to an autoimmune response.
55
Q

Describe the function of circulating B cells

A
  • Circulating B cells have a particularly important mechanism of sampling and presenting antigens.
  • They take up and process soluble extracellular pathogen antigens that are bound by the B cell receptor (BCR - see IMI3 if you have forgotten what this is).
  • The antigen is then internalised by receptor-mediated endocytosis, degraded in the lysosomal compartment, and presented on MHC class II, in much the same way as other antigens, as depicted in the image below.
  • The presentation from B cells to T helper cells, which was first explained to you in IMI3 is really important during B cell maturation.
  • The B cell will therefore receive T cell help only if there is a T cell that regards what its BCR has bound as a foreign antigen.
  • Conversely, the resulting activation of the B cell will make it release cytokines to polarise the T helper cell into T follicular helper cells, which feedback to B cells with the signals necessary to travel to a germinal centre, and mature into an antibody-producing B cell (ie a plasma cell) or memory B cell.
  • Plasma cells produce a large number of antibodies to fight the infection.
  • Memory B cells (more in IMI7) will be stored in case of future encounters with the same antigen.
  • These cells both recognise the antigen more specifically, can be rapidly activated, and subsequently proliferate and differentiate into plasma cells for a much faster response.
56
Q

What are the functions of the antibody

A
  • opsonisation:
  • Antibodies bind the target antigen with their variable region, while their constant region (Fc) is free to bind to Fc receptors on the surface of phagocytic cells, which can then internalise the antigen for MHC class II presentation.
  • neutralisation:
  • Neutralisation is a process whereby an antibody binds to a pathogen protein and blocks its function.
  • The figure shows examples of antibodies preventing a toxin (left), a virus (middle) and a bacterium (right) from binding its target.
  • This can stop viruses/bacteria from binding and entering a cell, or can stop toxins from binding and affecting their target proteins.
  • complement activation:
  • Antibodies activate the classical complement pathway. This is the only complement pathway that needs to use adaptive immune molecules for its activation.
57
Q

Describe some circumstances where a B cell response does not require T cell help

A
  • this occurs if certain stimuli such as T-independent antigens are bound by the BCR.
  • One example of T-independent antigens is highly repetitive structures – like bacterial (in particular) or viral (sometimes) surfaces – that have also been opsonised with complement.
  • This can cause many of the BCRs and complement receptors on the B cell to cluster together and activate the B cell, without T cell help (although they do need other danger signals, such as cytokines secreted by innate immune cells).
  • B cells activated in this way tend to make IgM, which is particularly good at both activating complement, and at binding to repetitive antigens, due to its pentameric structure.
58
Q

A naive B cell

A
59
Q

What are some mechanisms pathogens have evolved to escape antibody recognition?

A
  • antigenic variation:
  • Once an antibody response has been established against an extracellular pathogen, the microbe can evade this surveillance by altering its surface antigens.
  • You can think of antigenic variation as a sort of shuffling of the genes encoding surface proteins to produce ones that would not be recognised by antibodies from a previous infection.
  • It is very important for extracellular pathogens because it provides a population of pathogens with a wardrobe full of different outfits that can be used as camouflage from the antibody response.
  • Salmonella typhimurium can change their flagellin protein mid-infection!
  • When the bacterium receives signals indicating that the flagellum is not working (i.e. is coated with antibodies) it triggers a part of the bacterial genomic DNA to flip (an example of DNA rearrangement) switching to a new flagellin gene.
  • Streptococcus pneumoniae, the culprit of bacterial pneumonia, has evolved a polysaccharide capsule to protect itself from antibodies generated against other unencapsulated strains.
  • molecular mimicry:
  • To escape from immune surveillance, critical antigens of the infectious agent have evolved to closely resemble proteins of the host that the host immune system doesn’t detect as invaders but rather as self-antigens, so does not mount a response.
  • However, this poses a risk that in the eventuality of recognition the mimicked host protein can also be attacked, causing autoimmunity.
  • Enveloped viruses decorate their surface protein with glycans exploiting the glycosylation system of the host cell. In this way, they hide their antigens from the immune system using non-immunogenic glycans.
  • disruption of immune response:
  • We have already seen the example of superantigens, which impair the T cell response, which in turn interferes with the B cell response.
  • Also, a number of pathogens have evolved specifically to use immune cells as hosts, such as we saw with the Measles virus infecting B cells (IMI3 F2F), but also bacteria that set up home in macrophages or dendritic cells.
60
Q

Which of these are roles of DCs in the Peyer’s patch?

A
  • The correct answer is E-F-G-H-.
  • The Payers’ patches are secondary lymphoid organs that are structured similarly to the lymph node.
  • DCs sample antigen from the gut lumen either directly or indirectly (ie via M cells).
  • They then travel to the Peyers’ patches where naive T cells reside.
  • Here DCs present the sampled antigens and release IL-10.
  • By doing so they activate T cells and polarise them into T regulatory cells or T regs. T regs are now aware of the type of microorganisms present in the gut lumen and by secreting IL-10 they send a message of no danger.
  • T regs, in turn, will produce more IL-10 and TGF-Beta wich downplay the immune response.
61
Q

Where in the cell are bacteria recognised?

What happens after recognition?

A
  • Bacteria are recognised by PRRs on the cell surface (e.g. TLRs) or in the cytoplasm (e.g. NLRs such as NOD1 and NOD2) if bacterial products managed to get into the cell:
  • sentinel and circulating cells
  • Sensing triggers signalling that leads to NF-kB activation and
  • transcription of pro-inflammatory cytokines, chemokines and other mediators
  • which then recruit and activate neutrophils, macrophages and DCs to the site of
    infection
62
Q

What does bacteria activate that will tag and destroy them?

A
  • Bacteria also activate complement which will tag and destroy or sent off the pathogen to be destroyed (phagocytosis)
63
Q

What is intracellular infection and what does this trigger?

A
  • Intracellular infection (after bacterial products getting into the cytoplasm) can trigger the formation of the inflammasome, the most famous one being the NLRP3
  • composed of a NLR (e.g. NLRP3), an adapter molecule (ASC), and a caspase (casp 1)
  • Leads to activation of caspase 1
  • Which then leads to transcription of pro-inflammatory cytokines (e.g. IL-1, IL-18)
64
Q

How are bacteria that escape and invade the cytoplasm destroyed?

A
  • Bacteria that escape and invade the cytoplasm can be destroyed in autophagosomes after its fusion with lysosomes